Scandinavian Journal of Gastroenterology · 2019 · 16 citations · 19 references
MedicineOncologySurgeryGastrointestinal OncologyHepatologySurgical OncologyColorectal CancerColorectal SurgeryHepatobiliary SurgeryLiver CancerLiver DiseaseLiver MetastasisColorectal Liver MetastasisColorectal Metastatic Disease SurgeryLiver Disease PrognosisLiver Metastases ManagementLiver Metastasis ResectionLiver SurgeryMetastatic ResectionPostoperative Mortality
Background and aims: Expanded criteria for resection of colorectal liver metastases (CRLM) have led to a more aggressive surgical attitude. The aim is to evaluate any impact of expanded criteria on perioperative mortality and long-term survival.Materials and methods: A population based study from 2001 to 2015 for patients undergoing surgery for CRLM. The cohort was divided into three 5-year periods.Results: A total of 341 patients underwent resection of CRLM. Relative to the number of colorectal primaries, patients resected for CRLM increased from 82/2520 (3.3%) in 2001–2005 to 151/3071 (4.9%) in 2011–2015 (p = .007). The proportion of patients who underwent formal resections declined from 62% to 21%. There was a substantial increase in resections of synchronous liver metastases, portal vein embolizations, two-stage resections, and the share of octogenarians who underwent resection. The proportion of patients undergoing reresections of new liver recurrences increased from 6% to 24%. The 90-d postoperative mortality for 2001–2005, 2006–2010, and 2011–2015 were 7.9%, 0.8%, and 2.0%, respectively. The median overall survival was 47 months during the two first periods, for the last period not reached. The 5-year overall survival remained at 40% from 2001 to 2010, and estimated at 55.2% from 2011 to 2015. The 5-year disease-free survival was well above 30%. The 5-year overall survival following liver reresection was 52.6%.Conclusion: Postoperative mortality remained at approximately 2%, and the 5-year overall survival at 40% in the first 10 years, but increased to 55% in the last 5 years under study, despite a marked increase in resection rates.
19
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations
Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer
Yuman Fong, Joseph G. Fortner, Ruth L. Sun et al. · Annals of Surgery · 1999 · 3.7K citations · Full text
Bernard Nordlinger, Halfdan Sørbye, Bengt Glimelius et al. · The Lancet · 2008 · 1.9K citations · Full text
Andreas A. Schnitzbauer, Sven Arke Lang, Holger Goessmann et al. · Annals of Surgery · 2012 · 1.3K citations